TeichNMohlWBokemeyerB, et al. Azathioprine-induced acute pancreatitis in patients with inflammatory bowel diseases-a prospective study on incidence and severity. J Crohns Colitis. 2016;10(1):61-68. doi:10.1093/ecco-jcc/jjv188.
2.
GordonMGrafton-ClarkeCAkobengA, et al. Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review. Frontline Gastroenterol. 2021;12:423-436. doi:10.1136/flgastro-2020-101405.
3.
AloiMCucchiaraS.Acute pancreatitis and azathioprine in paediatric inflammatory bowel disease. Lancet Child Adolesc Health. 2019;3:131-132. doi:10.1016/S2352-4642(19)30019-7.
4.
SturdevantRASingletonJWDerenJLLawDHMcCleeryJL. Azathioprine-related pancreatitis in patients with Crohn’s disease. Gastroenterology. 1979;77(4, pt 2):883-886. doi:10.1016/0016-5085(79)90387-1.
5.
InoueHShirakiKOkanoH, et al. Acute pancreatitis in patients with ulcerative colitis. Dig Dis Sci. 2005;50(6):1064-1067. doi:10.1007/s10620-005-2705-7.
6.
MalloryAKernF.Drug-induced pancreatitis: a critical review. Gastroenterology. 1980;78(4):813-820. doi:10.1016/0016-5085(80)90689-7.
7.
NaranjoCABustoUSellersEM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. doi:10.1038/clpt.1981.15.
8.
ChouchanaLNarjozCBeaunePLoriotMARoblinX.The benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35(1):15-36. doi:10.1111/j.1365-2036.2011.04905.x.
9.
Álvarez BeltranMInfante PinaDTormo CarnicéRSegarra CantónORedecillas FerreiroS. Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites. An Pediatr (Barc). 2009;70(2):126-131. doi:10.1016/j.anpedi.2008.10.01010.1016/j.anpedi.2008.10.010.
10.
Gallego-GutiérrezSNavas-LópezVMKolorzM, et al. Successful mercaptopurine usage despite azathioprine-induced pancreatitis in paediatric Crohn’s disease. J Crohns Colitis. 2015;9(8):676-679. doi:10.1093/ecco-jcc/jjv086.
